Published in

Bentham Science Publishers, Letters in Drug Design & Discovery, 9(11), p. 1053-1061

DOI: 10.2174/1570180811666140322001506

Links

Tools

Export citation

Search in Google Scholar

Modeling the Active Conformation of Human µ Opioid Receptor

Journal article published in 2014 by Agnieszka A. Kaczor ORCID, Damian Bartuzi ORCID, Dariusz Matosiuk
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

G protein-coupled receptors (GPCRs) family, including opioid receptors, constitute one of the most important groups of drug targets. Chance for successful drug design for GPCRs can be increased by the availability of 3D structures of these proteins in their inactive (to bind antagonists) or active (to bind agonists) conformation. However, to date only few X-ray structures of GPCR-agonist complexes are known. The presented study aims to investigate the usage of single and multiple templates approach for homology modeling of the µ opioid receptor in its active conformation. The models are first assessed regarding their stereochemical and geometric correctness. Next, docking of two MOR agonists makes it possible to find the model with the most favourable conformation of binding site side chains. The study indicates that careful choice of templates and their proper alignment is particularly important in multi-template homology modeling, and that models based on a single template can be comparatively good as models based on multiple templates. Furthermore, it proves that use of only one template or template set may not be enough for obtaining the best possible homology model, and that building a set of models based on different template sets with subsequent comparative analysis can be beneficial approach. In particular, such a strategy can be useful to construct a model in a particular activation state or to reproduce ligand-specific rearrangement pattern, when supported with experimental data.